The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6277
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL) ; volume:23 ; number:3 ; day:8 ; month:3 ; year:2022 ; pages:381-403 ; date:3.2022
Current treatment options in oncology ; 23, Heft 3 (8.3.2022), 381-403, 3.2022
- Creator
-
Chu, Yaya
Lamb, Margaret
Cairo, Mitchell S.
Lee, Dean A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11864-021-00932-2
- URN
-
urn:nbn:de:101:1-2022060920021386328272
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chu, Yaya
- Lamb, Margaret
- Cairo, Mitchell S.
- Lee, Dean A.
- SpringerLink (Online service)
Other Objects (12)
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Cytokine expression in B-cell non-Hodgkin lymphomas
Current immunotherapeutic approaches in T cell non-Hodgkin lymphomas
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
NHL-2007 - familial predisposition for non-Hodgkin lymphomas in childhood and adolescence
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma